John Mascola
About John Mascola
CSO of ModeX Therapeutics
John Mascola is the Chief Scientific Officer (CSO) of ModeX Therapeutics. In this role, Mascola manages scientific strategies and oversees the development of therapeutic solutions. ModeX Therapeutics focuses on innovative treatments and precision medicine to combat a variety of diseases. Mascola's leadership in this position draws upon his vast experience in vaccine and antibody research.
Education and Medical Training
John Mascola earned his medical degree from Georgetown University, an institution known for its high standards in medical education. Following this, he completed a residency in internal medicine, which provided him with foundational clinical skills. He further specialized by completing a fellowship in infectious diseases, allowing him to gain in-depth knowledge and expertise in the diagnosis, treatment, and research of infectious diseases.
Career at Walter Reed Army Institute of Research
From 1993 to 2000, John Mascola served as a research physician at the Walter Reed Army Institute of Research. During his tenure, he focused on HIV immunology and vaccine development. His contributions in this role were significant, as they provided a deeper understanding of HIV and advanced the progress toward developing effective vaccines.
Director of Vaccine Research Center, NIAID, NIH
John Mascola was the Director of the Vaccine Research Center at the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) from 2013 to 2022. In this role, he oversaw critical research programs on vaccines and antibody therapeutics targeting major diseases like HIV, Ebola, respiratory syncytial virus, chikungunya, and malaria. His tenure included the establishment of collaborative partnerships that led to the licensure of therapeutic antibodies and vaccines for diseases such as Ebola and COVID-19.
Professional Associations and Recognitions
John Mascola has been elected to several prestigious organizations, including the American Society of Clinical Investigation, the Association of American Physicians, and the National Academy of Medicine. His contributions to the field have been recognized through these memberships. Additionally, he received the outstanding service medal from the U.S. Department of Health and Human Services, marking his significant impact on public health initiatives and medical research.